News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Upper and Lower GI Poster Discussion Session at ESTRO 2024
Photo from ESTRO/LinkedIn
Aug 2, 2024, 19:42

Upper and Lower GI Poster Discussion Session at ESTRO 2024

European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn:

“Spotlight on the latest in gastrointestinal cancer research from ESTRO 24: this congress report covers the packed Upper and Lower GI Poster Discussion Session, showcasing diverse pathologies, methodologies, and outcomes.”

Source: ESTRO/LinkedIn

cancer ESTRO ESTRO 2024 ESTRO 24 European SocieTy for Radiotherapy and Oncology gastrointestinal cancer research OncoDaily Oncology radiotherapy Upper and Lower GI Poster Discussion Session
Special Coverage
Science
Dec 21, 2024, 09:06
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial
Blog
Dec 21, 2024, 09:00
Miriam Mutebi: Does Nipple and Areola Size Matter?
Science
Dec 21, 2024, 08:51
Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis
Science
Dec 21, 2024, 08:48
Oncology Brothers: Another ALK inhibitor gets FDA approval
Science
Dec 21, 2024, 08:42
Eric K. Singhi: Decoding clinical trial jargon
Science
Dec 21, 2024, 08:37
Gustavo Viani: The Role of Radiotherapy on the management of HCC
Science
Dec 21, 2024, 08:29
Bishal Gyawali: The case of cancer drug Xtandi
Blog
Dec 21, 2024, 08:18
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers?
Career
Dec 21, 2024, 08:12
Rishabh Singh: Honored to receive the Mary Draeger Schultz Scholarship 2024
Science
Dec 21, 2024, 07:56
Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer
Career
Dec 21, 2024, 07:45
OncoInfluencers to Follow on Social Media: Dr. Liang Cheng
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer